Efficacy and safety of switching to bimatoprost or dorzoramide/timolol fixed-combination therapy from latanoprost monotherapy
Phase 4
- Conditions
- Primary open angle glaucoma or ocular hypertension
- Registration Number
- JPRN-UMIN000010081
- Lead Sponsor
- Association for research and science supporting for chronic diseases
- Brief Summary
Bimatoprost monotherapy and concomittant usage of brinzolamide to latanoprost monotherapy significantly reduce intraocular pressure compared with latanoprost monotherapy at the same level.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Other severe ocular diseases Contra-indication for experiment ophthalmic solutions Problems for intra-ocular pressure measurement
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intra-ocular pressure
- Secondary Outcome Measures
Name Time Method Ocular adverse effects